Spontaneous bruising as a possible adverse reaction to memantine

Internal Medicine Journal

Volumn 35, Issue 9, 2005, Pages 571-572

  Scharf, S L ^a   Parikh, S ^a   Dillon, L C ^a  

^a Caulfield General Medical Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; MEMANTINE;

AGED; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DOSE RESPONSE; FEMALE; HUMAN; LABORATORY TEST; LYMPHOCYTOPENIA; MENTAL HEALTH; MINI MENTAL STATE EXAMINATION; NEUTROPHIL; PRIORITY JOURNAL; SIDE EFFECT; SKIN BRUISING;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPARKINSON AGENTS; ECCHYMOSIS; FEMALE; HUMANS; MEMANTINE;

EID: 24744450735     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00874.x     Document Type: Article

References (5)

1. Caswell A (ed.). MIMS annual, Australian edition. MIMS Australia; 2004; 380.
2. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. Memantine in moderate to severe Alzheimer's disease. N Engl J Med 2003; 348: 1333-41.
3. Hartman S, Mobius HJ. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy. Int Clin Psychopharmacol 2003; 18: 81-5.
4. Franconi F, Miceli M, de Montis MG, Crisafi EL, Bennardini F, Tagliamonte A. NMDA receptors play an anti-aggregating role in human platelets. Thromb Haemost 1996; 76: 84-7.
5. Lidsky TI, Yablonsky-Alter E, Zuck LG, Banerjee SP. Antipsychotic drug effects on glutamatergic activity. Brain Res 1997; 764: 46-52.